

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.98081482 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.80269480 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.71745842 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.43629898 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.36650841 |
| 6 | presynaptic membrane assembly (GO:0097105) | 5.27630889 |
| 7 | vocalization behavior (GO:0071625) | 5.23806005 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.16627487 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.04813379 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.02238975 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.86355125 |
| 12 | presynaptic membrane organization (GO:0097090) | 4.82324588 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.74456077 |
| 14 | glutamate secretion (GO:0014047) | 4.73362485 |
| 15 | layer formation in cerebral cortex (GO:0021819) | 4.60839580 |
| 16 | behavioral response to nicotine (GO:0035095) | 4.55587736 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.52574573 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.42312906 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.41799052 |
| 20 | nucleobase catabolic process (GO:0046113) | 4.40134659 |
| 21 | protein localization to synapse (GO:0035418) | 4.39306753 |
| 22 | dendritic spine morphogenesis (GO:0060997) | 4.37364121 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.35766226 |
| 24 | neuronal action potential propagation (GO:0019227) | 4.35517954 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.34586535 |
| 26 | regulation of synapse structural plasticity (GO:0051823) | 4.31753721 |
| 27 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.29373662 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.28144677 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.21204665 |
| 30 | exploration behavior (GO:0035640) | 4.21024516 |
| 31 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.13107566 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.01031874 |
| 33 | proline transport (GO:0015824) | 3.95932573 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 3.95926865 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.93175176 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.92246466 |
| 37 | long-term memory (GO:0007616) | 3.88444732 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.85609342 |
| 39 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.84468674 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 3.81605126 |
| 41 | limb bud formation (GO:0060174) | 3.73158986 |
| 42 | axonal fasciculation (GO:0007413) | 3.71953941 |
| 43 | sodium ion export (GO:0071436) | 3.68475898 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.68077866 |
| 45 | neuron recognition (GO:0008038) | 3.67976237 |
| 46 | neurotransmitter transport (GO:0006836) | 3.67955612 |
| 47 | activation of protein kinase A activity (GO:0034199) | 3.62953002 |
| 48 | auditory behavior (GO:0031223) | 3.59228726 |
| 49 | positive regulation of membrane potential (GO:0045838) | 3.53611848 |
| 50 | dendrite morphogenesis (GO:0048813) | 3.52762570 |
| 51 | cell proliferation in forebrain (GO:0021846) | 3.51153797 |
| 52 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.50506797 |
| 53 | response to auditory stimulus (GO:0010996) | 3.49380930 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48786050 |
| 55 | neuromuscular process controlling posture (GO:0050884) | 3.48298023 |
| 56 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.43104671 |
| 57 | neuromuscular process controlling balance (GO:0050885) | 3.41691891 |
| 58 | prepulse inhibition (GO:0060134) | 3.41564614 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.40707320 |
| 60 | positive regulation of synapse maturation (GO:0090129) | 3.38766787 |
| 61 | cell communication by electrical coupling (GO:0010644) | 3.37306760 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.36324511 |
| 63 | glycine transport (GO:0015816) | 3.35550361 |
| 64 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.35262043 |
| 65 | synaptic vesicle endocytosis (GO:0048488) | 3.35234841 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 3.32722553 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.31819406 |
| 68 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.30413218 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.28681396 |
| 70 | startle response (GO:0001964) | 3.28009360 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26673762 |
| 72 | neuronal ion channel clustering (GO:0045161) | 3.26633413 |
| 73 | retinal ganglion cell axon guidance (GO:0031290) | 3.26301041 |
| 74 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25882778 |
| 75 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.24496818 |
| 76 | membrane depolarization during action potential (GO:0086010) | 3.22736640 |
| 77 | positive regulation of neurotransmitter transport (GO:0051590) | 3.20179030 |
| 78 | regulation of neurotransmitter secretion (GO:0046928) | 3.19070541 |
| 79 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.18700728 |
| 80 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.13735434 |
| 81 | long-term synaptic potentiation (GO:0060291) | 3.11384406 |
| 82 | cell migration in hindbrain (GO:0021535) | 3.10184711 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.09777127 |
| 84 | sulfation (GO:0051923) | 3.09515395 |
| 85 | membrane hyperpolarization (GO:0060081) | 3.08914210 |
| 86 | postsynaptic membrane organization (GO:0001941) | 3.08042833 |
| 87 | neuromuscular synaptic transmission (GO:0007274) | 3.07640292 |
| 88 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.06712853 |
| 89 | membrane depolarization (GO:0051899) | 3.05657772 |
| 90 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05518025 |
| 91 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.04942599 |
| 92 | synapse assembly (GO:0007416) | 3.04868009 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04585798 |
| 94 | response to pheromone (GO:0019236) | 3.04197267 |
| 95 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.03670772 |
| 96 | L-amino acid import (GO:0043092) | 3.02684965 |
| 97 | regulation of vesicle fusion (GO:0031338) | 3.01661054 |
| 98 | protein polyglutamylation (GO:0018095) | 2.99580833 |
| 99 | regulation of collateral sprouting (GO:0048670) | 2.98972686 |
| 100 | regulation of glucocorticoid secretion (GO:2000849) | 2.96747549 |
| 101 | positive regulation of dendritic spine development (GO:0060999) | 2.96055781 |
| 102 | cerebellar granule cell differentiation (GO:0021707) | 2.95093246 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 2.94939053 |
| 104 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.94605729 |
| 105 | cerebellar Purkinje cell layer development (GO:0021680) | 2.93330046 |
| 106 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.92449147 |
| 107 | spinal cord development (GO:0021510) | 2.92116387 |
| 108 | learning (GO:0007612) | 2.91275561 |
| 109 | adult walking behavior (GO:0007628) | 2.91099897 |
| 110 | establishment of nucleus localization (GO:0040023) | 2.89410584 |
| 111 | dendritic spine organization (GO:0097061) | 2.89365879 |
| 112 | mechanosensory behavior (GO:0007638) | 2.87300196 |
| 113 | dopamine receptor signaling pathway (GO:0007212) | 2.87294050 |
| 114 | regulation of synaptic transmission (GO:0050804) | 2.87291732 |
| 115 | synapse organization (GO:0050808) | 2.86284502 |
| 116 | neuromuscular process (GO:0050905) | 2.86037710 |
| 117 | negative regulation of axon guidance (GO:1902668) | 2.85822295 |
| 118 | otic vesicle formation (GO:0030916) | 2.84208795 |
| 119 | positive regulation of synapse assembly (GO:0051965) | 2.82168059 |
| 120 | central nervous system neuron axonogenesis (GO:0021955) | 2.80389687 |
| 121 | somite development (GO:0061053) | 2.74970716 |
| 122 | establishment of mitochondrion localization (GO:0051654) | 2.73916410 |
| 123 | negative regulation of axon extension (GO:0030517) | 2.72608839 |
| 124 | fear response (GO:0042596) | 2.65186281 |
| 125 | glycosphingolipid biosynthetic process (GO:0006688) | 2.62715297 |
| 126 | serotonin metabolic process (GO:0042428) | 2.60293581 |
| 127 | neuronal action potential (GO:0019228) | 2.59294757 |
| 128 | negative regulation of astrocyte differentiation (GO:0048712) | 2.58786549 |
| 129 | multicellular organismal signaling (GO:0035637) | 2.55698871 |
| 130 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.55530196 |
| 131 | behavioral fear response (GO:0001662) | 2.55023421 |
| 132 | behavioral defense response (GO:0002209) | 2.55023421 |
| 133 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.53794226 |
| 134 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.53792938 |
| 135 | hippocampus development (GO:0021766) | 2.53785669 |
| 136 | negative chemotaxis (GO:0050919) | 2.49611706 |
| 137 | regulation of axon guidance (GO:1902667) | 2.47720161 |
| 138 | regulation of neurotransmitter uptake (GO:0051580) | 2.47303932 |
| 139 | olfactory bulb development (GO:0021772) | 2.44469009 |
| 140 | negative regulation of response to food (GO:0032096) | 2.44239589 |
| 141 | negative regulation of appetite (GO:0032099) | 2.44239589 |
| 142 | regulation of timing of cell differentiation (GO:0048505) | 2.43440638 |
| 143 | regulation of synapse assembly (GO:0051963) | 2.42892776 |
| 144 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.42841514 |
| 145 | regulation of dendritic spine development (GO:0060998) | 2.42436050 |
| 146 | negative regulation of dendrite development (GO:2000171) | 2.42227709 |
| 147 | C4-dicarboxylate transport (GO:0015740) | 2.40455249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.24509582 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.23666277 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05775491 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93798578 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92405949 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.73512181 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68448035 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68448035 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.57457544 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.55409866 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52975839 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49550213 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49149824 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48215935 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45858488 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44985110 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41447054 |
| 18 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.27308898 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.26080723 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24542391 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23701027 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.21463352 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19432725 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12393922 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12185962 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07105080 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04205610 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.02160781 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.00189833 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.99185067 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93488430 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.89844652 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.84955443 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.78355115 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76475683 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.65613735 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62492041 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60090200 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53221579 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52246823 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50728545 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49518988 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49011614 |
| 44 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.43826708 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43249468 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42871197 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.39468688 |
| 48 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36278163 |
| 49 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35116824 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34067253 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32089958 |
| 52 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31438649 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30413499 |
| 54 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29875695 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28963892 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28073539 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27913716 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27800990 |
| 59 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27687048 |
| 60 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27687048 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25760694 |
| 62 | AR_19668381_ChIP-Seq_PC3_Human | 1.24747140 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24456816 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23502135 |
| 65 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.23336392 |
| 66 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23336392 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21856103 |
| 68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21536745 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21036422 |
| 70 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.20034663 |
| 71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17965019 |
| 72 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17385080 |
| 73 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16554666 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16052304 |
| 75 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.15724376 |
| 76 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15647172 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14748949 |
| 78 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.14681448 |
| 79 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14407815 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14298227 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13689365 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13224630 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12438323 |
| 84 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10427452 |
| 85 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09872046 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09569956 |
| 87 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09420034 |
| 88 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09128248 |
| 89 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08941299 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08726148 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08464467 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07050274 |
| 93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06479927 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05990825 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05919105 |
| 96 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05633397 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05517354 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04903601 |
| 99 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04832072 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04377369 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04354917 |
| 102 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04289934 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04080150 |
| 104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03182772 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03083815 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02405736 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02154942 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01807406 |
| 109 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01119771 |
| 110 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00995162 |
| 111 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00968227 |
| 112 | JUN_21703547_ChIP-Seq_K562_Human | 1.00650280 |
| 113 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00392386 |
| 114 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99292778 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99167455 |
| 116 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97900121 |
| 117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96439009 |
| 118 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.96297630 |
| 119 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96086441 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92844263 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92724518 |
| 122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91904860 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91122801 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91105049 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90854885 |
| 126 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87251411 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86392051 |
| 128 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86256694 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85702168 |
| 130 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84438237 |
| 131 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83912342 |
| 132 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83791016 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83779408 |
| 134 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.83488033 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82340697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.05038654 |
| 2 | MP0003880_abnormal_central_pattern | 4.33037641 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.98852007 |
| 4 | MP0004270_analgesia | 3.51107043 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.43035418 |
| 6 | MP0009745_abnormal_behavioral_response | 3.35088469 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.23342034 |
| 8 | MP0009046_muscle_twitch | 3.18236635 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.10864170 |
| 10 | MP0002064_seizures | 3.03034747 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.82378362 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.76197502 |
| 13 | MP0001486_abnormal_startle_reflex | 2.62100496 |
| 14 | MP0002822_catalepsy | 2.61896452 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.61237986 |
| 16 | MP0002272_abnormal_nervous_system | 2.45659068 |
| 17 | MP0003122_maternal_imprinting | 2.44461742 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.17737204 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.11650379 |
| 20 | MP0002102_abnormal_ear_morphology | 2.09440316 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.08850084 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.06845923 |
| 23 | MP0002557_abnormal_social/conspecific_i | 2.04961228 |
| 24 | MP0001984_abnormal_olfaction | 2.04543099 |
| 25 | MP0002067_abnormal_sensory_capabilities | 2.03262147 |
| 26 | MP0002736_abnormal_nociception_after | 1.96926672 |
| 27 | MP0004924_abnormal_behavior | 1.96299157 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.96299157 |
| 29 | MP0008569_lethality_at_weaning | 1.96003556 |
| 30 | MP0001970_abnormal_pain_threshold | 1.93393809 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.90196543 |
| 32 | MP0000778_abnormal_nervous_system | 1.89901572 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.86710411 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.86049711 |
| 35 | MP0002184_abnormal_innervation | 1.84270521 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.79565105 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.74811232 |
| 38 | MP0003787_abnormal_imprinting | 1.63907773 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.62132398 |
| 40 | MP0008789_abnormal_olfactory_epithelium | 1.60701629 |
| 41 | MP0001529_abnormal_vocalization | 1.55669119 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.55169963 |
| 43 | MP0000049_abnormal_middle_ear | 1.55077179 |
| 44 | MP0004885_abnormal_endolymph | 1.52609251 |
| 45 | MP0000955_abnormal_spinal_cord | 1.51985688 |
| 46 | MP0004858_abnormal_nervous_system | 1.48523633 |
| 47 | MP0003329_amyloid_beta_deposits | 1.47237484 |
| 48 | MP0001905_abnormal_dopamine_level | 1.45916707 |
| 49 | MP0003136_yellow_coat_color | 1.45819077 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.42949133 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.41574447 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.41365984 |
| 53 | MP0004133_heterotaxia | 1.35192723 |
| 54 | MP0002751_abnormal_autonomic_nervous | 1.32176148 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.30165196 |
| 56 | MP0003633_abnormal_nervous_system | 1.29465388 |
| 57 | MP0004142_abnormal_muscle_tone | 1.25658710 |
| 58 | MP0005253_abnormal_eye_physiology | 1.22669118 |
| 59 | MP0003938_abnormal_ear_development | 1.22617262 |
| 60 | MP0003879_abnormal_hair_cell | 1.22334392 |
| 61 | MP0000026_abnormal_inner_ear | 1.18503893 |
| 62 | MP0000751_myopathy | 1.18127703 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 1.17550055 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.17391703 |
| 65 | MP0002152_abnormal_brain_morphology | 1.14864150 |
| 66 | MP0002938_white_spotting | 1.14511213 |
| 67 | MP0003690_abnormal_glial_cell | 1.14273384 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.12742924 |
| 69 | MP0003121_genomic_imprinting | 1.12156436 |
| 70 | MP0003631_nervous_system_phenotype | 1.10585038 |
| 71 | MP0003119_abnormal_digestive_system | 1.03675111 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.01136493 |
| 73 | MP0002069_abnormal_eating/drinking_beha | 1.00090157 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 0.99004313 |
| 75 | MP0004134_abnormal_chest_morphology | 0.97696508 |
| 76 | MP0003137_abnormal_impulse_conducting | 0.97193518 |
| 77 | MP0004085_abnormal_heartbeat | 0.96831481 |
| 78 | MP0005499_abnormal_olfactory_system | 0.95782100 |
| 79 | MP0005394_taste/olfaction_phenotype | 0.95782100 |
| 80 | MP0005195_abnormal_posterior_eye | 0.94918051 |
| 81 | MP0002229_neurodegeneration | 0.91808684 |
| 82 | MP0002160_abnormal_reproductive_system | 0.90495152 |
| 83 | MP0001293_anophthalmia | 0.90152614 |
| 84 | MP0001177_atelectasis | 0.89821126 |
| 85 | MP0004742_abnormal_vestibular_system | 0.89163782 |
| 86 | MP0001188_hyperpigmentation | 0.89086181 |
| 87 | MP0003283_abnormal_digestive_organ | 0.88940844 |
| 88 | MP0005171_absent_coat_pigmentation | 0.88311772 |
| 89 | MP0003755_abnormal_palate_morphology | 0.88132041 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.86704789 |
| 91 | MP0003890_abnormal_embryonic-extraembry | 0.86579408 |
| 92 | MP0003634_abnormal_glial_cell | 0.86564843 |
| 93 | MP0000920_abnormal_myelination | 0.86190259 |
| 94 | MP0008872_abnormal_physiological_respon | 0.86100451 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 0.85202564 |
| 96 | MP0003123_paternal_imprinting | 0.82956710 |
| 97 | MP0003632_abnormal_nervous_system | 0.82721200 |
| 98 | MP0009250_abnormal_appendicular_skeleto | 0.82282154 |
| 99 | MP0002233_abnormal_nose_morphology | 0.82070518 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.81396623 |
| 101 | MP0010386_abnormal_urinary_bladder | 0.79966469 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.78099062 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.77360872 |
| 104 | MP0008874_decreased_physiological_sensi | 0.76449835 |
| 105 | MP0002249_abnormal_larynx_morphology | 0.76238668 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 0.76205453 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.75728635 |
| 108 | MP0000534_abnormal_ureter_morphology | 0.75327240 |
| 109 | MP0005535_abnormal_body_temperature | 0.74768817 |
| 110 | MP0001963_abnormal_hearing_physiology | 0.72495224 |
| 111 | MP0003942_abnormal_urinary_system | 0.72403820 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.72252196 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.71636683 |
| 114 | MP0005448_abnormal_energy_balance | 0.70894700 |
| 115 | MP0005391_vision/eye_phenotype | 0.69721303 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.69404381 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.68708179 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.68618475 |
| 119 | MP0003075_altered_response_to | 0.66455710 |
| 120 | MP0003861_abnormal_nervous_system | 0.63702975 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.60585836 |
| 122 | MP0005409_darkened_coat_color | 0.57189912 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.56940448 |
| 124 | MP0005187_abnormal_penis_morphology | 0.56710577 |
| 125 | MP0010769_abnormal_survival | 0.56153424 |
| 126 | MP0001943_abnormal_respiration | 0.56041575 |
| 127 | MP0010770_preweaning_lethality | 0.54923925 |
| 128 | MP0002082_postnatal_lethality | 0.54923925 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.53155382 |
| 130 | MP0000604_amyloidosis | 0.52601038 |
| 131 | MP0010768_mortality/aging | 0.52423694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.65784123 |
| 2 | Myokymia (HP:0002411) | 6.45713826 |
| 3 | Focal seizures (HP:0007359) | 5.43497687 |
| 4 | Visual hallucinations (HP:0002367) | 4.51626108 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.50973037 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.39454643 |
| 7 | Action tremor (HP:0002345) | 4.32342448 |
| 8 | Atonic seizures (HP:0010819) | 4.09872766 |
| 9 | Febrile seizures (HP:0002373) | 4.07715519 |
| 10 | Absence seizures (HP:0002121) | 3.93305288 |
| 11 | Papilledema (HP:0001085) | 3.83678361 |
| 12 | Ankle clonus (HP:0011448) | 3.75265282 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.74057717 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.61197103 |
| 15 | Broad-based gait (HP:0002136) | 3.55267850 |
| 16 | Dialeptic seizures (HP:0011146) | 3.51364285 |
| 17 | Truncal ataxia (HP:0002078) | 3.47854087 |
| 18 | True hermaphroditism (HP:0010459) | 3.35969378 |
| 19 | Pendular nystagmus (HP:0012043) | 3.31719487 |
| 20 | Poor eye contact (HP:0000817) | 3.28439519 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.26805739 |
| 22 | Agitation (HP:0000713) | 3.24661246 |
| 23 | Pancreatic fibrosis (HP:0100732) | 3.23675265 |
| 24 | Depression (HP:0000716) | 3.22993487 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.16746461 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.16556191 |
| 27 | Pancreatic cysts (HP:0001737) | 3.12165044 |
| 28 | Dysdiadochokinesis (HP:0002075) | 3.10402764 |
| 29 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.09911140 |
| 30 | Mutism (HP:0002300) | 3.08810997 |
| 31 | Dysmetria (HP:0001310) | 3.00461470 |
| 32 | Anxiety (HP:0000739) | 2.97563390 |
| 33 | Impaired social interactions (HP:0000735) | 2.95990400 |
| 34 | Abnormal social behavior (HP:0012433) | 2.95990400 |
| 35 | Postural instability (HP:0002172) | 2.95262146 |
| 36 | Genetic anticipation (HP:0003743) | 2.94816257 |
| 37 | Urinary urgency (HP:0000012) | 2.76529113 |
| 38 | Hemiplegia (HP:0002301) | 2.76052383 |
| 39 | Spastic gait (HP:0002064) | 2.73460645 |
| 40 | Nephronophthisis (HP:0000090) | 2.72076962 |
| 41 | Hemiparesis (HP:0001269) | 2.71624246 |
| 42 | Drooling (HP:0002307) | 2.67724427 |
| 43 | Excessive salivation (HP:0003781) | 2.67724427 |
| 44 | Septo-optic dysplasia (HP:0100842) | 2.67649358 |
| 45 | Abnormality of the corticospinal tract (HP:0002492) | 2.66173124 |
| 46 | Torticollis (HP:0000473) | 2.64387399 |
| 47 | Intention tremor (HP:0002080) | 2.63751876 |
| 48 | Progressive inability to walk (HP:0002505) | 2.62977167 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.58506729 |
| 50 | Polyphagia (HP:0002591) | 2.57350750 |
| 51 | Optic nerve hypoplasia (HP:0000609) | 2.55479660 |
| 52 | Scanning speech (HP:0002168) | 2.53021699 |
| 53 | Limb dystonia (HP:0002451) | 2.51579581 |
| 54 | Pheochromocytoma (HP:0002666) | 2.51080789 |
| 55 | Abnormality of midbrain morphology (HP:0002418) | 2.49910311 |
| 56 | Molar tooth sign on MRI (HP:0002419) | 2.49910311 |
| 57 | Lissencephaly (HP:0001339) | 2.48282342 |
| 58 | Abnormality of the labia minora (HP:0012880) | 2.48217183 |
| 59 | Termporal pattern (HP:0011008) | 2.47851029 |
| 60 | Insidious onset (HP:0003587) | 2.47851029 |
| 61 | Hyperventilation (HP:0002883) | 2.46690739 |
| 62 | Gait imbalance (HP:0002141) | 2.44270870 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.44231686 |
| 64 | Ventricular fibrillation (HP:0001663) | 2.41749167 |
| 65 | Lower limb muscle weakness (HP:0007340) | 2.38391616 |
| 66 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.37795212 |
| 67 | Amblyopia (HP:0000646) | 2.37694868 |
| 68 | Diplopia (HP:0000651) | 2.36336061 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.36336061 |
| 70 | Megalencephaly (HP:0001355) | 2.35982341 |
| 71 | Abnormal EKG (HP:0003115) | 2.35690868 |
| 72 | Focal dystonia (HP:0004373) | 2.33530016 |
| 73 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.33341203 |
| 74 | Medial flaring of the eyebrow (HP:0010747) | 2.32148916 |
| 75 | Abnormality of the lower motor neuron (HP:0002366) | 2.30507489 |
| 76 | Stereotypic behavior (HP:0000733) | 2.30122893 |
| 77 | Retinal dysplasia (HP:0007973) | 2.29826007 |
| 78 | Genital tract atresia (HP:0001827) | 2.29776243 |
| 79 | Failure to thrive in infancy (HP:0001531) | 2.28999995 |
| 80 | Dysmetric saccades (HP:0000641) | 2.27248566 |
| 81 | Vaginal atresia (HP:0000148) | 2.26940260 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.22448773 |
| 83 | Hypoplastic pelvis (HP:0008839) | 2.22316484 |
| 84 | Bradykinesia (HP:0002067) | 2.21563699 |
| 85 | Keratoconus (HP:0000563) | 2.19973527 |
| 86 | Increased corneal curvature (HP:0100692) | 2.19973527 |
| 87 | Sleep apnea (HP:0010535) | 2.19111319 |
| 88 | Epileptiform EEG discharges (HP:0011182) | 2.16914311 |
| 89 | Abolished electroretinogram (ERG) (HP:0000550) | 2.15880479 |
| 90 | Cystic liver disease (HP:0006706) | 2.15734557 |
| 91 | EEG with generalized epileptiform discharges (HP:0011198) | 2.15093161 |
| 92 | Sclerocornea (HP:0000647) | 2.13453668 |
| 93 | Absent speech (HP:0001344) | 2.13232687 |
| 94 | Craniofacial dystonia (HP:0012179) | 2.12285569 |
| 95 | Pointed chin (HP:0000307) | 2.12239869 |
| 96 | Insomnia (HP:0100785) | 2.10979652 |
| 97 | Obstructive sleep apnea (HP:0002870) | 2.10836043 |
| 98 | Pachygyria (HP:0001302) | 2.09820067 |
| 99 | Short 4th metacarpal (HP:0010044) | 2.09811571 |
| 100 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.09811571 |
| 101 | Clonus (HP:0002169) | 2.09255488 |
| 102 | Prolonged QT interval (HP:0001657) | 2.08949606 |
| 103 | Methylmalonic acidemia (HP:0002912) | 2.07026799 |
| 104 | Hypsarrhythmia (HP:0002521) | 2.06431146 |
| 105 | Status epilepticus (HP:0002133) | 2.05497007 |
| 106 | Chronic hepatic failure (HP:0100626) | 2.04892112 |
| 107 | Abnormality of the renal medulla (HP:0100957) | 2.04692232 |
| 108 | Decreased central vision (HP:0007663) | 2.04508326 |
| 109 | Type II lissencephaly (HP:0007260) | 2.04325367 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 2.04323996 |
| 111 | Congenital primary aphakia (HP:0007707) | 2.04050170 |
| 112 | Fetal akinesia sequence (HP:0001989) | 2.03013549 |
| 113 | Impaired vibratory sensation (HP:0002495) | 2.01785567 |
| 114 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.01588141 |
| 115 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01153827 |
| 116 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.99485109 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 1.98442622 |
| 118 | Inability to walk (HP:0002540) | 1.95789998 |
| 119 | Anencephaly (HP:0002323) | 1.94270345 |
| 120 | Congenital stationary night blindness (HP:0007642) | 1.93217013 |
| 121 | Annular pancreas (HP:0001734) | 1.92736992 |
| 122 | Blue irides (HP:0000635) | 1.92327398 |
| 123 | Incomplete penetrance (HP:0003829) | 1.91655507 |
| 124 | Aqueductal stenosis (HP:0002410) | 1.91564950 |
| 125 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.89594135 |
| 126 | Postural tremor (HP:0002174) | 1.88050398 |
| 127 | Abnormality of saccadic eye movements (HP:0000570) | 1.87794887 |
| 128 | Specific learning disability (HP:0001328) | 1.87731910 |
| 129 | Aplasia involving bones of the extremities (HP:0009825) | 1.87690576 |
| 130 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87690576 |
| 131 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87690576 |
| 132 | Psychosis (HP:0000709) | 1.87486042 |
| 133 | Gait ataxia (HP:0002066) | 1.86175254 |
| 134 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.85648506 |
| 135 | Postaxial hand polydactyly (HP:0001162) | 1.84812557 |
| 136 | Macroorchidism (HP:0000053) | 1.84395330 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.83932383 |
| 138 | Confusion (HP:0001289) | 1.83216134 |
| 139 | Small hand (HP:0200055) | 1.82785204 |
| 140 | Bundle branch block (HP:0011710) | 1.81582397 |
| 141 | Neoplasm of the heart (HP:0100544) | 1.81272470 |
| 142 | Abnormality of salivation (HP:0100755) | 1.81149093 |
| 143 | Cutaneous finger syndactyly (HP:0010554) | 1.77988505 |
| 144 | Short tibia (HP:0005736) | 1.76713332 |
| 145 | Tented upper lip vermilion (HP:0010804) | 1.75707529 |
| 146 | Intellectual disability, moderate (HP:0002342) | 1.75158679 |
| 147 | Absent septum pellucidum (HP:0001331) | 1.73635233 |
| 148 | Intestinal atresia (HP:0011100) | 1.70659521 |
| 149 | Thyroid-stimulating hormone excess (HP:0002925) | 1.70257470 |
| 150 | Renal hypoplasia (HP:0000089) | 1.68872920 |
| 151 | Oligodactyly (hands) (HP:0001180) | 1.68658347 |
| 152 | Humeroradial synostosis (HP:0003041) | 1.68101527 |
| 153 | Synostosis involving the elbow (HP:0003938) | 1.68101527 |
| 154 | Postaxial foot polydactyly (HP:0001830) | 1.68007894 |
| 155 | Hypoplasia of the brainstem (HP:0002365) | 1.66946552 |
| 156 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.66946552 |
| 157 | Methylmalonic aciduria (HP:0012120) | 1.65591269 |
| 158 | Morphological abnormality of the inner ear (HP:0011390) | 1.65316527 |
| 159 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.63791145 |
| 160 | Furrowed tongue (HP:0000221) | 1.63670443 |
| 161 | Chorioretinal atrophy (HP:0000533) | 1.63120371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.40524684 |
| 2 | MAP3K9 | 3.70952757 |
| 3 | MARK1 | 3.65210720 |
| 4 | EPHA4 | 3.44007149 |
| 5 | MAP3K4 | 3.10169376 |
| 6 | MINK1 | 2.78827232 |
| 7 | NTRK2 | 2.67598458 |
| 8 | MAP4K2 | 2.53170590 |
| 9 | MAP2K7 | 2.49434871 |
| 10 | FRK | 2.35388445 |
| 11 | PAK6 | 2.31759729 |
| 12 | DAPK2 | 2.07045281 |
| 13 | PRKD3 | 1.93597004 |
| 14 | BMPR1B | 1.93433325 |
| 15 | MAP2K4 | 1.92502973 |
| 16 | TNIK | 1.90141556 |
| 17 | CAMKK1 | 1.89326190 |
| 18 | DYRK2 | 1.83825115 |
| 19 | KSR1 | 1.77399886 |
| 20 | MAP3K12 | 1.75806871 |
| 21 | KSR2 | 1.65228800 |
| 22 | GRK1 | 1.60284374 |
| 23 | TRIM28 | 1.59172699 |
| 24 | CDK5 | 1.56509525 |
| 25 | ADRBK2 | 1.56275616 |
| 26 | NTRK1 | 1.54059819 |
| 27 | UHMK1 | 1.53887371 |
| 28 | MAPK13 | 1.53793548 |
| 29 | SIK2 | 1.50897103 |
| 30 | CASK | 1.49347345 |
| 31 | STK38 | 1.48932009 |
| 32 | CDK19 | 1.48380596 |
| 33 | TYRO3 | 1.38829196 |
| 34 | PHKG1 | 1.36811969 |
| 35 | PHKG2 | 1.36811969 |
| 36 | EPHB2 | 1.27400377 |
| 37 | SIK3 | 1.26221414 |
| 38 | CSNK1G3 | 1.25484710 |
| 39 | INSRR | 1.18638339 |
| 40 | PRKCG | 1.16823517 |
| 41 | CSNK1A1L | 1.16544870 |
| 42 | CSNK1G1 | 1.16459774 |
| 43 | PNCK | 1.15909755 |
| 44 | AKT3 | 1.09609162 |
| 45 | WNK3 | 1.08834693 |
| 46 | FES | 1.08195883 |
| 47 | PRPF4B | 1.07473631 |
| 48 | SGK223 | 1.02282579 |
| 49 | SGK494 | 1.02282579 |
| 50 | CAMKK2 | 1.01327449 |
| 51 | PLK2 | 1.00490387 |
| 52 | GRK5 | 0.99226625 |
| 53 | DAPK1 | 0.97305061 |
| 54 | RIPK4 | 0.97045519 |
| 55 | CAMK1 | 0.96282169 |
| 56 | PRKCH | 0.95744408 |
| 57 | CDK18 | 0.94831902 |
| 58 | PAK3 | 0.94823600 |
| 59 | NUAK1 | 0.94744391 |
| 60 | LATS2 | 0.93747410 |
| 61 | RIPK1 | 0.92971368 |
| 62 | FGFR2 | 0.92404041 |
| 63 | MKNK2 | 0.91401577 |
| 64 | CAMK2A | 0.90688962 |
| 65 | TAOK1 | 0.89099364 |
| 66 | CDK15 | 0.88137482 |
| 67 | BCR | 0.87771445 |
| 68 | STK11 | 0.87664611 |
| 69 | LMTK2 | 0.85875237 |
| 70 | CDK14 | 0.85331521 |
| 71 | RET | 0.84991114 |
| 72 | PKN1 | 0.84733995 |
| 73 | CAMK1G | 0.82013181 |
| 74 | MAP3K2 | 0.81619801 |
| 75 | CSNK1G2 | 0.80709073 |
| 76 | OXSR1 | 0.80396435 |
| 77 | ARAF | 0.79486759 |
| 78 | ALK | 0.78178486 |
| 79 | MARK2 | 0.78088496 |
| 80 | SGK2 | 0.77241836 |
| 81 | PINK1 | 0.76798111 |
| 82 | CDK11A | 0.76165692 |
| 83 | EPHA3 | 0.74759153 |
| 84 | ZAK | 0.73918346 |
| 85 | DYRK1A | 0.71135305 |
| 86 | SGK3 | 0.69951317 |
| 87 | CAMK2B | 0.69769868 |
| 88 | STK38L | 0.69678707 |
| 89 | SGK1 | 0.67998927 |
| 90 | CDC42BPA | 0.67643502 |
| 91 | WNK4 | 0.67473817 |
| 92 | WNK1 | 0.66378295 |
| 93 | ACVR1B | 0.65517754 |
| 94 | STK39 | 0.63119686 |
| 95 | MAP3K13 | 0.61897713 |
| 96 | PRKCZ | 0.59750725 |
| 97 | VRK1 | 0.59495850 |
| 98 | PRKCE | 0.58332868 |
| 99 | CSNK1A1 | 0.57937252 |
| 100 | TLK1 | 0.56628709 |
| 101 | CAMK4 | 0.54161678 |
| 102 | PDPK1 | 0.54158840 |
| 103 | TNK2 | 0.53874800 |
| 104 | NEK6 | 0.53268218 |
| 105 | PDK1 | 0.53209943 |
| 106 | CSNK1D | 0.52251257 |
| 107 | RPS6KA3 | 0.52195524 |
| 108 | SRPK1 | 0.50972702 |
| 109 | MAPK10 | 0.50588380 |
| 110 | ERBB3 | 0.50258299 |
| 111 | PLK3 | 0.49958966 |
| 112 | MKNK1 | 0.46816550 |
| 113 | FYN | 0.46805895 |
| 114 | PRKACA | 0.45933601 |
| 115 | CAMK2D | 0.45636379 |
| 116 | CDK3 | 0.44852570 |
| 117 | CDC7 | 0.44172202 |
| 118 | PRKD2 | 0.43672254 |
| 119 | FER | 0.43662842 |
| 120 | CAMK2G | 0.42837250 |
| 121 | DYRK3 | 0.42806640 |
| 122 | ADRBK1 | 0.41506334 |
| 123 | DMPK | 0.41494801 |
| 124 | RAF1 | 0.41316305 |
| 125 | STK16 | 0.40687605 |
| 126 | MAP3K1 | 0.40594681 |
| 127 | CCNB1 | 0.38636978 |
| 128 | MAPK15 | 0.38064293 |
| 129 | MAP3K6 | 0.37021637 |
| 130 | CSNK1E | 0.35748566 |
| 131 | OBSCN | 0.35518357 |
| 132 | PRKCB | 0.35083142 |
| 133 | PDGFRA | 0.34461156 |
| 134 | MAP2K6 | 0.34151972 |
| 135 | PTK2B | 0.34071451 |
| 136 | TIE1 | 0.32299404 |
| 137 | DDR2 | 0.31711423 |
| 138 | PRKG1 | 0.31688618 |
| 139 | ROCK1 | 0.31275877 |
| 140 | ERBB2 | 0.31226182 |
| 141 | ROCK2 | 0.31047021 |
| 142 | PRKDC | 0.30848087 |
| 143 | PRKACB | 0.30837427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.82299647 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.11355977 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.96948569 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.81695791 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68021373 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.65334861 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.62608381 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.53897435 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.26196119 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.18994341 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17576726 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16043977 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.04576818 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.00150557 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89696819 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.85605474 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80219652 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76748853 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.74694746 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73166235 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.73077992 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.72916236 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70846026 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.59701254 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59551110 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.59079662 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52969298 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.52733516 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49577243 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41778522 |
| 31 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.40750577 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.37627125 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37169667 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37004901 |
| 35 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.30424178 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28172436 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27893698 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27773364 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26522301 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.26152796 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24804780 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24770920 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17224391 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.16925848 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 1.16793988 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16293945 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.14430989 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13281856 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10176838 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09676820 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08842914 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07633883 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07240180 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06051388 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 1.02243492 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00864838 |
| 57 | Glioma_Homo sapiens_hsa05214 | 1.00723784 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00080510 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97662092 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97623308 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90896791 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89789883 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89037643 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88975806 |
| 65 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.87375063 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86183074 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82960966 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81578096 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81388871 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81077329 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80330516 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79300915 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79254272 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78091070 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75535357 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73891359 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.73654835 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70684529 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70229529 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.70161856 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69907734 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67019145 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66814734 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66389765 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64406800 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63973444 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63804932 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62524347 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62308699 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61946362 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.61295531 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60734517 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.60521736 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59035986 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.58523263 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58511853 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58304676 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.57713387 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57572396 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57414484 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57166646 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54927766 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54680718 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53632674 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52903538 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52793713 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52013549 |
| 108 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50253511 |
| 109 | RNA degradation_Homo sapiens_hsa03018 | 0.49905562 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49833020 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.49394713 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49183231 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48490097 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48322696 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48236352 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47711512 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47608663 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47201115 |
| 119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46580165 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46341862 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45434427 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44768145 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44543616 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43606017 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43469062 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42793097 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.42456697 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.40754804 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40369012 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40225747 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39505588 |
| 132 | RNA polymerase_Homo sapiens_hsa03020 | 0.38923531 |
| 133 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37376959 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36587647 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35895012 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35128236 |
| 137 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33456178 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32674194 |
| 139 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30888116 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30370050 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29063772 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26229323 |

